DexCom
DXCM
932 hedge funds and large institutions have $24.8B invested in DexCom in 2025 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 376 increasing their positions, 312 reducing their positions, and 115 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 376 | Existing positions reduced: 312
19% more call options, than puts
Call options by funds: $401M | Put options by funds: $337M
1.45% more ownership
Funds ownership: 91.84% → 93.29% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
5% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 115
2% less funds holding
Funds holding: 950 → 932 (-18)
11% less capital invested
Capital invested by funds: $27.9B → $24.8B (-$3.06B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$239M |
| 2 |
Jennison Associates
New York
|
+$235M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$165M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$164M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$156M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$223M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$191M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$174M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$98.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$68.9M |
DXCM Hedge Fund Activity: Q1 2025 in Review
932 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2025, worth a combined $24.8B — down 11% from $27.9B a quarter earlier.
Sellers outnumbered buyers: 115 funds closed out of DXCM and 109 opened new positions — a net loss of 6 holders — while 312 trimmed existing stakes and 376 added.
The largest buyer was UBS AM, adding an estimated $239M. The largest seller was Millennium Management, cutting an estimated $223M.
- 932 institutional investors held DexCom (DXCM) as of Q1 2025, down from 950 in Q4 2024.
- Funds reported $24.8B of DexCom stock for Q1 2025, down 11% quarter-over-quarter.
- 109 funds opened new DexCom positions in Q1 2025 and 115 closed out, a net change of -6 holders.
- The largest DexCom buyer in Q1 2025 was UBS AM, an estimated $239M added.
- The largest DexCom seller in Q1 2025 was Millennium Management, an estimated $223M sold.
Based on aggregated 13F filings for Q1 2025.